Bionano Genomics Inc.

BNGO | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.83

+$0.10 (+5.78%)

At close: Sep 21, 2026, 4:00 PM ET

$1.87

+$0.04 (+2.19%)

After-hours: Sep 21, 2026, 7:56 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+5.78%

(1D)

Rating

Updated: Aug 28, 2026

33.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $21M

1D Range

1.76 1.86

52W Range

1 2.23

Valuation (TTM)

PE -0.41

PB 0.66

EV/EBITDA -0.79

Valuation (NTM)

Forward PE N/A

Forward PEG 0.01

Price Target $46.50

Cash Flow

FCF Yield -97.5%

SBC Adj. FCF Yield -114.2%

SBC Impact -17.1%

Margins

Gross Margin 47.5%

Operating Margin -106.7%

FCF Margin -67.9%

Growth (CAGR)

Revenue 3Y | 5Y -1.4% | 18.0%

Dil EPS 3Y | 5Y 149.5% | 47.5%

FCF 3Y | 5Y 84.8% | 36.0%

Returns

ROA -67.6%

ROE -78.8%

ROIC -83.8%

Financial Health

Net Cash

$9.92M

Current Ratio 2.48

Interest Coverage -151.12

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Bionano Genomics, Inc. focuses on providing advanced solutions for analyzing genomes. The company's flagship offering is Saphyr, a complete system that processes samples to results, enabling the analy...

Sector Healthcare

Industry Medical - Instruments & Supplies

Employees 96

IPO Date Aug 20, 2018

Website bionano.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 12, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+173.22%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞